首页> 外文会议>5th International Photodynamic Association Biennial Meeting >Urothelial conversion of 5-aminolevulinic acid to protoporphyrin IX following oral or intravesical administration
【24h】

Urothelial conversion of 5-aminolevulinic acid to protoporphyrin IX following oral or intravesical administration

机译:口服或膀胱内给药后5-氨基乙酰丙酸的尿道转化为原卟啉IX

获取原文

摘要

Abstract: Preferential conversion of 5-aminolevulinic acid (5-ALA) to protoporphyrin-IX (Pp-IX) occurs in malignant tissue, with accumulation to diagnostic and therapeutic levels. Recent studies have suggested selective conversion in epithelial tissue following oral or intravenous administration. Topical application avoids systemic photosensitization. However, the glycosaminoglycan (GAG) layer lining the urinary bladder is believed to be a protective barrier generally limiting mucosal absorption. Our objective was to evaluate uptake and conversion of 5-ALA following intravesical or oral administration. Using a rat model, Pp-IX content within epithelial and muscularis layers was quantitated by fluorescence confocal microscopy. Following intravesical administration, Pp-IX accumulated predominantly in the urothelium; whereas following oral administration, Pp-IX accumulated in both the urothelium and muscularis. Intravesical 5-ALA administration is feasible and may afford selective photosensitization of the urothelium for treatment of carcinoma in situ. !23
机译:摘要:恶性组织中5-氨基乙酰丙酸(5-ALA)优先转化为原卟啉-IX(Pp-IX),并积累到诊断和治疗水平。最近的研究表明口服或静脉内给药后上皮组织中的选择性转化。局部应用可避免全身性光敏作用。但是,膀胱内衬的糖胺聚糖(GAG)层被认为是通常限制粘膜吸收的保护性屏障。我们的目标是评估膀胱内或口服后5-ALA的摄取和转化。使用大鼠模型,通过荧光共聚焦显微镜定量上皮层和肌层内的Pp-IX含量。膀胱内给药后,Pp-IX主要积累在尿路上皮中;而口服后,Pp-IX累积在尿路上皮和肌层中。膀胱内5-ALA给药是可行的,并且可以提供尿路上皮的选择性光敏性以治疗原位癌。 !23

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号